Home>IPO>Krsnaa Diagnostics Ltd.

Krsnaa Diagnostics IPO

Krsnaa Diagnostics Ltd.

₹13,995 /15 sharesMinimum Investment

IPO Listing Details

Listed OnIssue PriceListing PriceListing Gains
BSE & NSE₹954₹1,006+₹52.00 (5.45%)

IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
4 Aug ‘21 - 6 Aug ‘21₹13,99515₹933 - ₹954
Issue SizeIPO Doc
1213.33Cr
RHP PDFopen_in_new

Subscription Rate As on 6th Aug 2021, 8:00 PM

  • Retail Individual Investor
    42.04x
  • Non-Institutional Investor
    116.30x
  • Qualified Institutional Buyers
    49.83x
  • Employees
    0.98x

About Company

Krsnaa Diagnostics Limited is a large and differentiated diagnostic service provider. It provides a range of technology-enabled diagnostic services such as imaging (including radiology), pathology/clinical laboratory, and teleradiology services to public and private hospitals, medical colleges, and community health centers across India. It is the fastest-growing diagnostic chain in India on multiple parameters. The company has an extensive network of integrated diagnostic centers across India primarily in non-metro and lower-tier cities and towns.
... Read More
Parent Organisation
Krsnaa Diagnostics Ltd.
Founded
2010
Managing Director
Pallavi Bhatevara

Strengths & Risks

  • add
    Unique and scaled diagnostics company.
  • add
    Brand is associated with providing quality and reliable healthcare services at affordable prices.
  • add
    As of December 31, 2020, its network of diagnostic centers spans 13 states across India in over 1,800 locations.
  • add
    Business model with robust revenue visibility.
  • add
    Well-positioned to capitalize on healthcare spending across public and private sectors.
  • add
    Scalable and agile business model with an efficient cost structure.
  • add
    Consistent track record of financial performance.
  • add
    Ability to maintain cost competitiveness through operating leverage.
  • add
    Experienced promoters and management team supported by a strong employee base.
  • remove
    Significant dependence on payments under contracts with public health agencies.
  • remove
    Most of its diagnostic centers have been established and are operated under PPP contracts awarded by government agencies through a competitive bidding process. Company may not successfully win these tenders in the future.
  • remove
    Continuing impact of the outbreak of the COVID-19.
  • remove
    Dependency on its information technology systems and the telecommunication network in India in providing diagnostic services and managing its operations.
  • remove
    Prices charged for the diagnostic services are dependent on recommended or mandatory fees fixed under the terms of the agreements entered into with public and private healthcare providers.
  • remove
    Delays in the establishment of diagnostic centers resulting in the termination of the agreements or cost overruns.
  • remove
    Capital-intensive business.
  • remove
    Any failure to comply with the legal and regulatory requirements.
  • remove
    Failure to establish and comply with appropriate quality standards when performing imaging, testing, and diagnostics services.
  • remove
    Inability to obtain, retain, or renew the required approvals, licenses, registrations, and permits for conducting its business.
  • remove
    Highly competitive industry – the diagnostics industry in India.
  • remove
    Dependency on third parties for testing equipment and reagents.
  • remove
    Any inadequacy in packaging, collection of, or failure, or delay in the delivery of, specimens to its diagnostic centers resulting in the specimens getting compromised or destroyed.

Financials

*All values are in Rs. Cr
No Graph Data To Display
ⓒ 2016-2021 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 1.9.0
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES: ICICI PRUDENTIAL  | HDFC  | NIPPON INDIA  | ADITYA BIRLA SUN LIFE  | SBI  | UTI  | FRANKLIN TEMPLETON  | KOTAK MAHINDRA  | IDFC  | DSP  | AXIS  | TATA  | L&T  | SUNDARAM  | PGIM  | INVESCO  | LIC  | JM FINANCIAL  | BARODA PIONEER  | CANARA ROBECO  | HSBC  | IDBI  | INDIABULLS  | MOTILAL OSWAL  | BNP PARIBAS  | MIRAE ASSET  | PRINCIPAL  | BOI AXA  | UNION KBC  | TAURUS  | EDELWEISS  | NAVI  | MAHINDRA  | QUANTUM  | PPFAS  | IIFL  | Quant  | SHRIRAM  | SAHARA | ITI
ABOUT GROWW
keyboard_arrow_down
arrow_drop_down_circle